Aldosterone production is activated in failing ventricle in humans

Circulation

Volumn 103, Issue 1, 2001, Pages 72-77

  Mizuno, Yuji ^a   Yoshimura, Michihiro ^b   Yasue, Hirofumi ^a,d   Sakamoto, Tomohiro ^b   Ogawa, Hisao ^b   Kugiyama, Kiyotaka ^b   Harada, Eisaku ^b   Nakayama, Masafumi ^b   Nakamura, Shota ^b   Ito, Teruhiko ^b   Shimasaki, Yukio ^b   Saito, Yoshihiko ^c   Nakao, Kazuwa ^c  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d Kumamoto Aging Research Institute   (Japan)

Author keywords

Aldosterone; Angiotensin; Angiotensin converting enzyme; B type natriuretic peptide; Ventricles

Indexed keywords

ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; AORTA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; CORRELATION FUNCTION; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE OVERLOAD; HORMONE SYNTHESIS; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0035830440     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.1.72     Document Type: Article

References (31)

1. Hormones in the pathogenesis of congestive heart failure: Vasopressin, aldosterone, angiotensin II
2. Circulating versus local renin-angiotensin system in cardiovascular homeostasis
3. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality: CONSENSUS trial study group
4. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system
5. Mineralocorticoids, hypertension, and cardiac fibrosis
6. Isolation and characterization of rat CYP11B genes involved in late steps of mineralo- and glucocorticoid syntheses
7. Vascular aldosterone: Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells
8. Aldosterone biosynthesis in the rat brain
9. Myocardial production of aldosterone and corticosterone in the rat: Physiological regulation
10. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis
11. Origin of great cardiac vein and coronary sinus drainage within the left ventricle
12. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy
13. Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, ANP and BNP
14. Localization and mechanism of secretion of B-type natriuretic peptides in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
15. Cardiac angiotensin-converting enzyme activity in myocardial infarction
16. Fundamental and clinical studies on SPAC-S Aldosterone RIA Kit
17. Colorimetry of angiotensin-I converting enzyme activity in serum
18. An immunoradiometric assay for brain natriuretic peptide in human plasma
19. Prerequisite for cardiac aldosterone action: Mineralocorticoid receptor and 11 β-hydroxysteroid dehydrogenase in the human heart
20. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated
21. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure
22. Regulation of aldosterone secretion
23. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements
24. Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor
25. Inhibition of aldosterone production by an atrial extract
26. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function
27. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure
28. Chronic administration of aldosterone depresses baroreceptor reflex function in the dog
29. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease
30. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators